Epidermal Growth Factor Receptor Variant III Mutation, an Emerging Molecular Marker in Glioblastoma Multiforme Patients: A Single Institution Study on the Indian Population

Background Glioblastoma is the most frequent and the most aggressive primary malignant brain tumor in adults. Standard treatment includes surgical removal of the tumor followed by concomitant chemotherapy and radiotherapy. Temozolomide, an oral alkylating agent, is currently the most commonly used c...

Descripción completa

Detalles Bibliográficos
Autores principales: Garima, Garima, Thanvi, Sharad, Singh, Anurag, Verma, Vijay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Pathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335135/
https://www.ncbi.nlm.nih.gov/pubmed/35911278
http://dx.doi.org/10.7759/cureus.26412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335135/
https://www.ncbi.nlm.nih.gov/pubmed/35911278
http://dx.doi.org/10.7759/cureus.26412

Ejemplares similares